GlassScriptPhysician profile
Jaime Durzo
NPI 1831366210
$3,589.78
in general payments reported to CMS, 2019-2025
14 companies · $435 in 2025
The $435 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $501 · 2022: $851 · 2023: $1,075 · 2024: $728 · 2025: $435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,237.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,105.38 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $420.43 | 2022-2024 | Sotyktu |
| Incyte Corporation | $234.84 | 2021-2024 | Opzelura |
| Genzyme Corporation | $219.60 | 2021-2023 | |
| Regeneron Healthcare Solutions, INC. | $187.30 | 2021-2025 | Dupixent |
| Sun Pharmaceutical Industries INC. | $106.47 | 2022-2023 | Winlevi |
| Novartis Pharmaceuticals Corporation | $79.92 | 2021-2023 | |
| Janssen Biotech, INC. | $57.03 | 2022-2023 | Tremfya |
| Biofrontera INC. | $56.64 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $38.69 | 2024 | |
| Galderma Laboratories, L.P. | $29.14 | 2025 | Aklief |
| Mayne Pharma Commercial LLC | $21.50 | 2023-2025 | |
| Ucb, INC. | $18.20 | 2021 | |
| Pfizer INC. | $14.64 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Durzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.